Ruvidar Demonstrates 7 Year Complete Response
Patient Diagnosed with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In-Situ Treated Once with Light-Activated Ruvidar(TM) ...
Theralase Technologies Inc.: Ruvidar Demonstrates 7 Year Complete Response
Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research ...
Medscape6d
Acute Liver Failure in Children
Acute liver failure (ALF) in children differs from that observed in adults in both the etiologic spectrum and the clinical picture. Children, particularly very young ones, do not demonstrate ...
Indiatimes23h
Simplex Infrastructures Share Price
Simplex Infrastructures Ltd., incorporated in the year 1924, is a Small Cap company (having a market cap of Rs 1,835.43 Crore) operating in Construction sector. Simplex Infrastructures Ltd. key ...
Frontiers3d
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Natural killer (NK) cells are the predominant innate lymphocyte subsets that mediate anti-tumor and anti-viral responses, and therefore possess promising clinical utilization. NK cells do not express ...